Hello Friends,
After careful consideration, I decided to join this trial. Since I was diagnosed in 2017 I have been on Hydrea, Interferon and Angerlide. Recently my platelets spiked over the millions so my MPN Specialist, Dr Gotlib at Stanford, suggested this trial. I was hesitant at first but the more research I did, I realized I didn't want to pass up this opportunity. So I muscled through the screening process and was approved. They did notice in my BMB, a slight progression, but my diagnosis was still the same. All the more reason to move forward with the trial. After my first dose, I'm happy to report that my platelets have gone from 1 million to 618,000 and my LDH level went down 50% in just one week. Wow! I've never seen my numbers shift this much. I feel great, just dealing with some fatigue. Because my numbers were excellent, Dr. Shomali (head of the trial) took me off of Anagrelide. What a relief! My next infusion is this Monday and going forward I will receive infusions every 2 weeks. In 6 months I will get another BMB to see if the disease is essentially reversing.
Stanford is looking for more patients to join phase one of the trial. If you live in California, or are willing to travel and are interested in this opportunity, below is the link.
clinicaltrials.gov/study/NC...
I'll keep this forum update through any journey. Onward!